NCSH in the News
Other News This Week
|
This Week
|
|
|
|
|
The First 'Female Viagra' is Here. Who Wants It? - Washington Post
In August, the FDA approved flibanserin, also known as Addyi, for premenopausal women diagnosed with sexual desire dysfunction. Here's how it works and why some are calling it a game changer.
Safety Issues with First Female Libido Pill May Spur Better Alternatives for Women - US News and World Report
Most women with low sexual desire won't rush to get the first prescription drug to boost female libido when it becomes available on Saturday, but they may have more options down the road.
Amidst all the debate about campus sexual assault, there are still questions about the scope of the problem. Two graduate students at Stanford suggest a way to better determine its prevalence.
Sexually Transmitted Diseases in the US Military: Syphilis Cases See 41% Rise Since 2010 - International Business Times
The US Navy in the past month has seen nine new cases of syphilis in its ranks, as many diagnoses as giardia, Lyme disease and salmonella combined.
Heirs to the Sexual Revolution - New York Magazine
As part of a "Sex on Campus" package, New York Magazine polled more than 700 college students around the country about the hookup and sex cultures on their campuses.
'Greater Than AIDS' Campaign Brings Attention to Higher Rate of Intimate Partner Violence among Women with HIV/AIDS - Medical Daily
Intimate partner violence, or domestic violence, affects one in three women in the US, but among women who also have HIV/AIDS, this incidence climbs to one in two.
While Viagra is an FDA-approved drug to treat erectile dysfunction, there are also over-the-counter supplements for sexual enhancement that claim to be "all-natural" or "herbal," but are not approved by the FDA, and do not undergo safety testing.
|
